Amarin Corp. Plc
| Nasdaq: AMRN
Amarin Corp. Plc is a biopharmaceutical company, which is focused on the commercialization and development of therapeutics to improve cardiovascular health. The company's lead product Vascepa capsules is an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. The company is also developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol. Amarin was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.